Mupitas is a novel topical broad spectrum antibiotic for the treatment bacterial skin infections. Mupitas ointment  contains Mupirocin 2% weight/weight. Mupirocin is a topical antibacterial agent, active against those organisms responsible for the majority of skin infections, e.g. Staphylococcus aureus, including methicillin-resistant strains, other staphylococci and streptococci. It is also active against Gram-negative pathogens, such as Escherichia coli and Heamophilus influenza.

Absorption & Excretion:

Mupitas penetrates intact human skin but the rate of systemic absorption appears to be low. Systemically absorbed Mupitas  is rapidly metabolized to the inactive metabolite monic acid and quickly excreted by the kidneys.

Bacterial skin infections, e.g. impetigo, folliculitis and furunculosis.

Adults and Children: Mupitas should be applied to the affected area up to three times daily, for up to 10 days. The area may be covered with a dressing or occluded if desired. There is no long term experience of Mupitas in humans.

During clinical trials some minor adverse effects, localized to the area of application, were seen, such as burning sensation, stinging and itching. Cutaneous sensitization reactions have been reported rarely. Systemic allergic reactions have been reported with Mupitas ointment.

This Mupitas formulation is not suitable for ophthalmic or intra-nasal use. When Mupitas is used on the face care should be taken to avoid the eyes. Mupirocin should be used with caution if there is evidence of moderate or severe renal impairment.

Hypersensitivity to Mupirocin or other ointments containing any of its constituents.

N/A

Store in a cool and dry place, protected from light. Keep out of reach of the children.